|
211 |
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
Enthalten in npj Genomic Medicine Bd. 10, 20.11.2025, Nr. 1, date:12.2025: 1-21
|
|
|
|
212 |
Glioma patients in outpatient care—optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trial
Enthalten in Trials Bd. 21, 27.5.2020, Nr. 1, date:12.2020: 1-10
|
|
|
|
213 |
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
Enthalten in Human genetics Bd. 130, 20.5.2011, Nr. 5, date:11.2011: 685-699
|
|
|
|
214 |
High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy
Enthalten in Journal of cancer research and clinical oncology Bd. 146, 18.12.2019, Nr. 1, date:1.2020: 127-136
|
|
|
|
215 |
High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma
Enthalten in Journal of cancer research and clinical oncology Bd. 139, 28.4.2013, Nr. 8, date:8.2013: 1295-1302
|
|
|
|
216 |
High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy
Enthalten in BMC cancer Bd. 18, 16.4.2018, Nr. 1, date:12.2018: 1-9
|
|
|
|
217 |
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy
Enthalten in BMC cancer Bd. 22, 9.4.2022, Nr. 1, date:12.2022: 1-12
|
|
|
|
218 |
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Enthalten in Breast cancer research Bd. 18, 21.6.2016, Nr. 1, date:12.2016: 1-21
|
|
|
|
219 |
JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer’s disease
Enthalten in Nature Communications Bd. 14, 4.12.2023, Nr. 1, date:12.2023: 1-16
|
|
|
|
220 |
Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway
Enthalten in BMC pharmacology & toxicology Bd. 18, 17.6.2017, Nr. 1, date:12.2017: 1-14
|
|
Administration
